1 / 64

Hypertensive Emergencies

Hypertensive Emergencies. Phillip D. Levy, MD, MPH, FACEP Associate Professor Associate Director of Clinical Research Wayne State University Department of Emergency Medicine. Relevant Disclosures. Grant/Research Support

vila
Télécharger la présentation

Hypertensive Emergencies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hypertensive Emergencies Phillip D. Levy, MD, MPH, FACEP Associate Professor Associate Director of Clinical Research Wayne State University Department of Emergency Medicine

  2. Relevant Disclosures • Grant/Research Support • The Robert Wood Johnson Foundation Physician Faculty Scholars Program, the NIH Loan Repayment Program (Health Disparities Division), and the NIH/NIHMD (1R01 MD005849-01A1) • Consultant • The Medicines Company, EKR Therapeutics

  3. Purpose of This Lecture • To provide an overview of the “what” and “why” of contemporary ED management of acute HTN • Utilize an evidence-based discussion format • Focus on differentiation between simple BP elevation and true hypertensive emergency

  4. Why This Topic? Nawar et al. Adv Data 2007; 386:1-32.

  5. Why This Topic? Pitts et al. Natl Health Stat Report 2008;7:1-38.

  6. Based on JNC VII Class http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm

  7. Reflects the General Population Prevalence Lloyd-Jones et al. Circulation 2010;121;e1-e170.

  8. As Well As Racial and Ethnic Demographics Lloyd-Jones et al. Circulation 2010;121;e1-e170.

  9. And Low Levels of Awareness, Treatment and Control Lloyd-Jones et al. Circulation 2010;121;e1-e170.

  10. So The BP is High - Now What ? http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm

  11. So The BP is High - Now What ? http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm

  12. So The BP is High - Now What ? http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm

  13. Shayne and Pitts. Ann Emerg Med. 2003;41:513-29.

  14. Are All of These Patients the Same? Kessler and Joudeh. Am Fam Physician. 2010;81:470-76.

  15. Clearly Not! Kessler and Joudeh. Am Fam Physician. 2010;81:470-76.

  16. What Constitutes a Hypertensive Emergency? 1,2 1 Varon and Marik. Chest 2000;118:214-27. 2 Rynn et al. J Pharm Prac 2005;18:363-76.

  17. Pathophysiology of aHypertensive Emergency1,2 1 Ault and Ellrodt. Am J Emerg Med 1985; (suppl 6):10-15. 2 Varon and Marik. Chest. 2000;118:214-27.

  18. Chirinos and Segers. Hypertension 2010;56:563-70.

  19. Macrocirculatory:Arterial Impedance Kawaguchi et al. Circulation 2003;107:714-20.

  20. What End-Organs Are Typically Involved? Zampaglione et al. Hypertension 1996;27:144–7.

  21. Katz et al. Am Heart J 2009;158:599-606.

  22. Patient Outcomes Katz et al. Am Heart J 2009;158:599-606.

  23. Szczech et al. Circulation 2010;121:2183-91.

  24. Deshmukh et al. Am Heart J. 2011 [epub ahead of print].

  25. Stead et al. Neurology 2005;65:1179-83.

  26. Gheorghiade et al. JAMA 2006;296:2217-26.

  27. Perez et al. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003653.

  28. Perez et al. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003653.

  29. Treatment Typically Parenteral • Adrenergic receptor blockers • Esmolol (β1) • Labetalol (α1 and β) • Phentolamine (α1) • Urapidil (α1) • Ca2+ channel blockers • Nicardipine • Clevidipine • ACE inhibitors • Enalaprilat • NO donors • Nitroprusside • Nitroglycerin • Isosorbidedinitrate • NP analogue • Nesiritide • Dopamine agonist • Fenoldopam • Direct vasodilator • Hydralazine

  30. What Is Used Most Commonly? Katz et al. Am Heart J 2009;158:599-606.

  31. How Well Does That Work? Katz et al. Am Heart J 2009;158:599-606.

  32. Differential Antihypertensive Response Katz et al. Am Heart J 2009;158:599-606.

  33. Blood Pressure Dynamics • MAP = DBP + ([SBP - DBP]/3) • MAP = (CO x SVR) + CVP • CO = HR x SV

  34. Reference: Peacocket al. Peacock et al. Critical Care 2011 [epub ahead of print].

  35. CLUE Study Evaluation of Intravenous niCardipine and LabetalolUse in the Emergency Department Reference: Peacocket al. Peacock et al. Critical Care 2011 [epub ahead of print].

  36. CLUE Study Evaluation of Intravenous niCardipine and LabetalolUse in the Emergency Department Final multivariable logistic regression model†* for “met target SBP within first 30 minutes” Reference: Peacocket al. Peacock et al. Critical Care 2011 [epub ahead of print].

  37. Specific Indications Rhoney and Peacock. Am J Health-Syst Pharm. 2009; 66:1343-52.

  38. How Low Should You Go? • Simple answer • 25% reduction in MAP within 1st hour • Target ~ 160/100 mm Hg by 2-6 hours Marik and Varon. Critical Care 2003, 7:374-84.

  39. How Low Should You Go? • Better answer • It really depends on clinical condition • Less aggressive with ischemic stroke • More aggressive with hemorrhagic stroke, acute HF and aortic dissection

  40. AHA/ASA Recommendations for BP Management in AIS Aiyagari and Gorelick. Stroke 2009;40:2251-56.

  41. AHA/ASA Recommendations for BP Management in AIS Aiyagari and Gorelick. Stroke 2009;40:2251-56.

  42. AHA/ASA Recommendations for BP Management in AIS Aiyagari and Gorelick. Stroke 2009;40:2251-56.

  43. AHA/ASA Recommendations for BP Management in ICH Aiyagari and Gorelick. Stroke 2009;40:2251-56.

  44. AHA/ASA Recommendations for BP Management in ICH Aiyagari and Gorelick. Stroke 2009;40:2251-56.

  45. Sandset et al. Lancet 2011 [epub ahead of print].

  46. Sandset et al. Lancet 2011 [epub ahead of print].

  47. Sandset et al. Lancet 2011 [epub ahead of print].

  48. Impact of Early Reduction Rhoney et al. Presented at the 2011 Neuro-Critical Care Society Meeting.

  49. Impact of Early Reduction Rhoney et al. Presented at the 2011 Neuro-Critical Care Society Meeting.

  50. Guideline: SBP < 180 mm Hg Intensive: SBP < 140 mm Hg Anderson et al. Stroke 2010;41:307-12.

More Related